Turn Therapeutics Inc. (TTRX) stock

TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30

$9.35−0.79 (-7.75%)

Close on Nov 13, 2026Market cap $278.37MP/E –Yield –

Turn Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Turn Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?